You are here

Article info

Article menu
Download PDFPDF
Original research
Moral obligations in conducting stem cell-based therapy trials for autism spectrum disorder

Authors

  • Nicole Shu Ling Yeo-Teh Research Compliance and Integrity Office, National University of Singapore, Singapore PubMed articlesGoogle scholar articles
  • Bor Luen Tang Research Compliance and Integrity Office, National University of Singapore, Singapore Department of Biochemistry, Yong Loo Lin School of Medicine, National University Health System, National University of Singapore, Singapore PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nicole Shu Ling Yeo-Teh, Research Compliance and Integrity Office, National University of Singapore, Singapore; dprysln{at}nus.edu.sg; Dr Bor Luen Tang; bchtbl{at}nus.edu.sg
View Full Text

Citation

Yeo-Teh NSL, Tang BL
Moral obligations in conducting stem cell-based therapy trials for autism spectrum disorder
Journal of Medical Ethics 2022;48:343-348.

Publication history

  • Received November 26, 2020
  • Revised March 4, 2021
  • Accepted March 20, 2021
  • First published April 15, 2021.
Online issue publication 
April 25, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Other content recommended for you